Á lódáil...
Trailblazing Precision Oncology for Rare Tumor Subtypes
Molecular Tumor Boards seek to recommend therapeutics to patients based on varying levels of evidence linking specific genetic alterations to treatment response. This commentary highlights the study by Kato and colleagues, which reports the usage of precision medicine approaches in rare and ultra‐ra...
Na minha lista:
| Foilsithe in: | Oncologist |
|---|---|
| Main Authors: | , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
AlphaMed Press
2017
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5813755/ https://ncbi.nlm.nih.gov/pubmed/29158369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0494 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|